VCYT VERACYTE, INC.
Nasdaq · SEC CIK 1384101 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $22.25M 37 sales by 11 insiders
- Filings on record
- 275 since 2021-07-20, latest 2026-09-22 17:16
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Stapley Marc | CEO, Dir | — | $8.92M |
| JONES EVAN/ FA | Dir | — | $2.00M |
| Chambers Rebecca | CFO | — | $1.91M |
| McGuire Annie | SVP, GC | — | $1.80M |
| Wygant Jonathan | VP, CAO | — | $1.54M |
| EASTHAM KARIN | Dir | — | $1.49M |
| Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| Leite John | Gbl Chief Commercial Off | — | $1.34M |
| EPSTEIN ROBERT S | Dir | — | $1.19M |
| Holstein Jens | Dir | — | $628.3K |
Transactions 342
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-16 | 2022-06-16 | VCYT | Bhanji Muna | Dir | A - Grant | $0.00 | +14.7K | 26.3K | +128% | $0 | |
| 2022-06-16 | 2022-06-16 | VCYT | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +14.7K | 23.5K | +169% | $0 | |
| 2022-06-16 | 2022-06-16 | VCYT | EASTHAM KARIN | Dir | A - Grant | $0.00 | +14.7K | 23.5K | +169% | $0 | |
| 2022-06-13 | 2022-06-10 | VCYT | Stapley Marc | CEO, Dir | P - Purchase | $16.33 | +60.0K | 159.8K | +60% | +$979.8K | |
| D | 2022-06-10 | 2022-06-08 | VCYT | GORDON KEVIN K | Dir | M - OptEx | $7.39 | +15.0K | 23.7K | +172% | +$110.8K |
| D | 2022-06-10 | 2022-06-08 | VCYT | GORDON KEVIN K | Dir | S - Sale+OE | $18.50 | -15.0K | 8,720 | -63% | -$277.5K |
| 2022-06-06 | 2022-06-02 | VCYT | Stapley Marc | CEO, Dir | F - Tax | $18.23 | -4,047 | 99.8K | -4% | -$73.8K | |
| 2022-06-06 | 2022-06-02 | VCYT | Anderson Bonnie H | Executive COB, Dir | F - Tax | $18.23 | -2,042 | 67.0K | -3% | -$37.2K | |
| 2022-06-06 | 2022-06-02 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | F - Tax | $18.23 | -1,008 | 60.4K | -2% | -$18.4K | |
| 2022-05-03 | 2022-05-01 | VCYT | Anderson Bonnie H | Executive COB, Dir | F - Tax | $20.47 | -736 | 86.0K | -0.8% | -$15.1K | |
| DMA | 2022-03-09 | 2022-03-04 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $25.12 | -23.0K | 67.3K | -25% | -$578.5K |
| DA | 2022-03-09 | 2022-03-04 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $5.98 | +4,407 | 84.4K | +6% | +$26.4K |
| DA | 2022-03-09 | 2022-03-03 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | A - Grant | $0.00 | +42.4K | 80.0K | +113% | $0 |
| D | 2022-03-07 | 2022-03-03 | VCYT | Anderson Bonnie H | Executive COB, Dir | A - Grant | $0.00 | +17.7K | 86.7K | +26% | $0 |
| D | 2022-03-07 | 2022-03-03 | VCYT | Chambers Rebecca | CFO | A - Grant | $0.00 | +20.7K | 54.7K | +61% | $0 |
| D | 2022-03-07 | 2022-03-03 | VCYT | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +56.5K | 103.8K | +120% | $0 |
| D | 2022-03-07 | 2022-03-03 | VCYT | Nova Tina Susan | Pres, CLIA U.S | A - Grant | $0.00 | +56.5K | 77.0K | +277% | $0 |
| DM | 2022-03-07 | 2022-03-04 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $25.12 | -23.0K | 61.4K | -27% | -$577.8K |
| D | 2022-03-07 | 2022-03-04 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $5.98 | +4,407 | 84.4K | +6% | +$26.4K |
| D | 2022-03-07 | 2022-03-03 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | A - Grant | $0.00 | +42.4K | 80.0K | +113% | $0 |
| 2022-03-04 | 2022-03-02 | VCYT | Anderson Bonnie H | Executive COB, Dir | F - Tax | $27.84 | -4,521 | 69.0K | -6% | -$125.9K | |
| 2022-03-04 | 2022-03-02 | VCYT | Nova Tina Susan | Pres, CLIA U.S | F - Tax | $27.84 | -10.7K | 20.4K | -34% | -$297.7K | |
| 2022-03-04 | 2022-03-02 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | F - Tax | $27.84 | -10.3K | 37.6K | -22% | -$287.8K | |
| D | 2022-03-02 | 2022-02-28 | VCYT | McGuire Annie | SVP, GC | A - Grant | $0.00 | +22.9K | 22.9K | New | $0 |
| D | 2022-01-13 | 2022-01-11 | VCYT | JONES EVAN/ FA | Dir | M - OptEx | $4.00 | +5,000 | 43.7K | +13% | +$20.0K |
| D | 2021-12-20 | 2021-12-17 | VCYT | EASTHAM KARIN | Dir | M - OptEx | $12.12 | +5,000 | 13.7K | +57% | +$60.6K |
| D | 2021-12-20 | 2021-12-17 | VCYT | EASTHAM KARIN | Dir | S - Sale+OE | $45.00 | -5,000 | 8,720 | -36% | -$225.0K |
| D | 2021-12-10 | 2021-12-09 | VCYT | Anderson Bonnie H | Executive COB, Dir | M - OptEx | $8.86 | +11.3K | 73.5K | +18% | +$100.0K |
| DM | 2021-12-08 | 2021-12-06+ | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $17.97 | +14.3K | 53.4K | +37% | +$256.6K |
| DM | 2021-12-08 | 2021-12-06+ | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $37.71 | -15.4K | 49.7K | -24% | -$579.1K |
| 2021-12-06 | 2021-12-02 | VCYT | Anderson Bonnie H | Executive COB, Dir | F - Tax | $39.22 | -2,288 | 62.3K | -4% | -$89.7K | |
| 2021-12-06 | 2021-12-02 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | F - Tax | $39.22 | -912 | 49.0K | -2% | -$35.8K | |
| 2021-11-03 | 2021-11-01 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | F - Tax | $51.80 | -149 | 49.9K | -0.3% | -$7,718 | |
| MIE | 2021-11-03 | 2021-11-01 | VCYT | EASTHAM KARIN | Dir | S - Sale | $32,978.71 | -4,400 | 1,241 | -78% | — |
| I | 2021-09-21 | 2021-09-17 | VCYT | Anderson Bonnie H | Executive COB, Dir | S - Sale | $50.18 | -2,600 | 217.5K | -1% | -$130.5K |
| I | 2021-09-14 | 2021-09-10 | VCYT | Anderson Bonnie H | Executive COB, Dir | S - Sale | $50.03 | -1,900 | 220.1K | -0.9% | -$95.1K |
| DM | 2021-09-09 | 2021-09-07+ | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $50.55 | -13.5K | 50.0K | -21% | -$680.2K |
| DM | 2021-09-09 | 2021-09-07 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $16.77 | +12.5K | 59.1K | +27% | +$210.2K |
| 2021-09-07 | 2021-09-02 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | F - Tax | $52.97 | -912 | 51.0K | -2% | -$48.3K | |
| 2021-09-07 | 2021-09-02 | VCYT | Anderson Bonnie H | Executive COB, Dir | F - Tax | $52.97 | -2,288 | 64.5K | -3% | -$121.2K | |
| MI | 2021-08-04 | 2021-08-02 | VCYT | EASTHAM KARIN | Dir | S - Sale | $43.90 | -4,400 | 5,954 | -42% | -$193.2K |
| D | 2021-07-20 | 2021-07-19 | VCYT | Chambers Rebecca | CFO | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations